Treatment for Psychotic Disorders

3
Effectiveness
3
Safety
Henderson Behavioral Health, Lauderdale Lakes, FL
Psychotic Disorders+1 More
Eligibility
< 65
All Sexes
Eligible conditions
Psychotic Disorders

Study Summary

This study is evaluating whether a program which identifies patients at risk for disengagement from care and provides them with support may help them stay engaged in care.

See full description

Eligible Conditions

  • Psychotic Disorders
  • First Episode Psychosis (FEP)

Treatment Effectiveness

Effectiveness Estimate

3 of 3
This is better than 93% of similar trials

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Psychotic Disorders. Measurement will happen over the course of Minimum of 6 months.

Minimum of 6 months
Disengagement rate

Trial Safety

Safety Estimate

3 of 3
This is better than 85% of similar trials

Trial Design

1 Treatment Groups

Control

This trial requires 300 total participants across 1 different treatment groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: minimum of 6 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly minimum of 6 months for reporting.

Closest Location

Henderson Behavioral Health - Lauderdale Lakes, FL

Eligibility Criteria

This trial is for patients born any sex aged 65 and younger. There is one eligibility criterion to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Enrolled into a CSC program

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Psychotic Disorders by sharing your contact details with the study coordinator.